Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TED”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Early research (Phase 1)Looking for participantsNCT06569758
What this trial is testing

GenSci098 in Subjects With Active Thyroid Eye Disease

Who this might be right for
SafetyTolerabilityGenSci098+1 more
Changchun GeneScience Pharmaceutical Co., Ltd. 76
Testing effectiveness (Phase 2)Looking for participantsNCT07547930
What this trial is testing

Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease, TEDGraves OphthalmopathyGraves Orbitopathy
The First Affiliated Hospital of Xiamen University 8
Post-approval studies (Phase 4)Looking for participantsNCT07152340
What this trial is testing

The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.

Who this might be right for
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital 64
Large-scale testing (Phase 3)Active Not RecruitingNCT06625398
What this trial is testing

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 204
Large-scale testing (Phase 3)Not Yet RecruitingNCT07622108
What this trial is testing

Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study

Who this might be right for
Thyroid Eye Disease, TED
Minghui Pharmaceutical (Hangzhou) Ltd 84
Large-scale testing (Phase 3)Active Not RecruitingNCT06812325
What this trial is testing

A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease (TED)
Viridian Therapeutics, Inc. 320
Large-scale testing (Phase 3)Active Not RecruitingNCT07211776
What this trial is testing

Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease (TED)
Zai Lab (Shanghai) Co., Ltd. 108
Early research (Phase 1)Ended earlyNCT06467435
What this trial is testing

Evaluation of K9 in Subjects With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Peter Timoney 4
Testing effectiveness (Phase 2)Study completedNCT01868997
What this trial is testing

Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease

Who this might be right for
Thyroid Associated OphthalmopathiesThyroid-Associated Ophthalmopathy
Amgen 88
Large-scale testing (Phase 3)Study completedNCT02949362
What this trial is testing

Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study

Who this might be right for
Short Bowel Syndrome
Shire 29
Early research (Phase 1)Study completedNCT07142642
What this trial is testing

Evaluate Pharmacokinetics, Safety, and Tolerability of Teprotumumab (AMG 632) Administered Intravenously in Healthy Chinese Participants

Who this might be right for
Healthy Volunteers
Amgen 20
Large-scale testing (Phase 3)Study completedNCT06021054
What this trial is testing

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 188
Not applicableStudy completedNCT01915797
What this trial is testing

Tumor and Development (TED)

Who this might be right for
Tumor and Abnormalities of the Development
Assistance Publique - Hôpitaux de Paris 998
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07594912
What this trial is testing

Teprotumumab N01 Versus Methylprednisolone After Urgent Orbital Decompression for Dysthyroid Optic Neuropathy

Who this might be right for
Thyroid Eye Disease, TEDGraves OphthalmopathyOptic Neuropathy
Sun Yat-sen University 60
Not applicableStudy completedNCT07056114
What this trial is testing

Multi-modal Medical Images for Extraocular Muscle Fibrosis Assessment

Who this might be right for
Thyroid Eye Disease, TED
Tianjin Eye Hospital 58
Large-scale testing (Phase 3)Study completedNCT05987423
What this trial is testing

Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

Who this might be right for
Thyroid Eye DiseaseTED
Hoffmann-La Roche 131
Testing effectiveness (Phase 2)Study completedNCT05683496
What this trial is testing

Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
ACELYRIN Inc. 31
Large-scale testing (Phase 3)Study completedNCT07155668
What this trial is testing

A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 87
Not applicableStudy completedNCT03099031
What this trial is testing

Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE)

Who this might be right for
Venous Thromboembolism
LEO Pharma 420
Not applicableEnrolling By InvitationNCT07679477
What this trial is testing

Management of Myopia in University Students With DIMS-TED Spectacle Lenses

Who this might be right for
Myopia Progression
University of Bradford 38
Next Page